VivoSim Labs, Inc.

VivoSim Labs, Inc.

VIVS - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.79M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
VivoSim Labs, Inc.VivoSim Labs, Inc.0--142%-0.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.79 Million
Enterprise Value$-3,250,210.00
Earnings per Share$-5.35
Beta1.56
Outstanding Shares16,445,249

Return

Return on Equity-141.78%ROE
Return on Assets-103.47%
Return on Invested Capital-166.87%

Valuation & Multiples

P/E Ratio-0.03P/E Ratio
PEG0.04PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-43.97
Enterprise Value to EBIT0.49
Enterprise Value to Net Income0
Total Debt to Enterprise-0.09
Debt to Equity0.07Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 12, 2026
EPS
-$0.03
Reported
Revenue
$51,000
Est. $130.00 M

Next Earnings Call

Expected Date
February 9, 2027
EPS Estimate
-$5.16
Consensus analyst estimate
Revenue Estimate
$46,532
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %9.66%▲ 7.69%
Total Invested$107,471▼ 2.04%
Investors Holding15▼ 9.00%

About Organovo Holdings Inc

15 employees
CEO: Keith Murphy

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicolo...

VivoSim Labs Insider Information FAQ

Stockcircle shows 1 open-market insider purchase for VivoSim Labs in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.